CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Astonea Labs Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Astonea Labs Ltd
Village Haripur, Tehsil Raipur
PANCHKULA, 134204  India Ticker: 544409544409
Business Summary
Astonea Labs Limited is an India-based company, which specializes in the manufacturing and marketing of a range of pharmaceutical and cosmetic products. These include antibiotic drugs, anti-cold medications, antihistamines, and drugs for diabetes, cardiovascular diseases, gynecological concerns, analgesics, fungal infections, and multivitamins. The Company also offers products for skin, tooth, and hair care, available in various forms, such as gels, ointments, creams, lotions, oils, and serums. Additionally, the Company is also involved in the trading of certain packing materials and raw materials used in pharmaceutical and cosmetic products. It manufactures and markets its own products under the brands Glow Up and Regero in the domestic market, wherein the products under Glow Up are also available through e-commerce platforms like Amazon and Tata 1MG. The Company also exports its products directly to countries such as Iraq and Yemen.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20243/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
2836 Biological products, except diagnostic substances

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Financial Officer SumitKumar 4/1/2024 4/1/2024
Compliance Officer, Company Secretary AvneetKaur 5/6/2024 5/6/2024
Managing Director, Executive Director AshishGulati 32 4/11/2022 4/11/2022
4 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 10,511,000 (As of 6/3/2025)
Stock Exchange: BOM


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, June 6, 2025